Variables | Training Cohort (n = 900) | Internal validation Cohort (n = 300) | External validation Cohort (n = 387) | P value |
---|---|---|---|---|
Age (years) | 49 (42, 58) | 49 (41, 55) | 52 (45, 59) | <0.001 |
Sex, Male / Female | 782 (86.9) / 118 (13.1) | 261 (87.0) / 39 (13.0) | 344 (88.9) / 43 (1.11) | <0.001 |
Height (cm) | 166 (161, 170) | 165 (160, 170) | 165 (161, 170) | 0.936 |
Weight (kg) | 61 (55, 68) | 60 (54, 67) | 60 (54,69) | 0.540 |
BMI (kg/m2) | 22.3 (20.0, 24.4) | 21.8 (20.0, 24.5) | 22.1 (20.1, 24.5) | 0.540 |
Hypertension, Yes / No | 67 (7.4%) / 833 (92.6%) | 19 (6.3%) / 281 (93.7%) | 54 (14.0%) / 333 (86.0%) | <0.001 |
Diabetes, Yes / No | 83 (9.2%) / 817 (90.8%) | 21 (7.0%) / 279 (93.0%) | 29 (7.5%) / 358 (92.5%) | 0.373 |
HBsAg, Positive / Negative | 259 (28.8%) / 641 (71.2%) | 81 (27.0%) / 219 (73.0%) | 90 (23.3%) / 297 (96.7%) | 0.124 |
HBV-DNA, ≥2000 / < 2000 (IU/ml) | 555 (61.7%) / 345 (38.4%) | 179 (59.7%) / 121 (40.3%) | 175 (45.2%) / 212 (54.8%) | <0.001 |
PLT (× 109/L) | 199.9 (155.0, 260.0) | 207.1 (160.0, 261.7) | 149.0 (100.0, 193.0) | <0.001 |
T-Bil (μmol/L) | 12.9 (9.5, 17.2) | 13.0 (9.7, 17.8) | 14.2 (10.7, 18.9) | <0.001 |
PA (mg/L) | 178.0 (135.0, 224.0) | 173.0 (130.0, 217.0) | 202.0 (150.0, 244.0) | <0.001 |
ALB (g/L) | 39.6 ± 4.6 | 39.3 ± 4.8 | 41.5 ± 4.4 | <0.001 |
ALT (U/L) | 36.0 (24.0, 52.5) | 34.0 (25.0, 49.0) | 34.0 (24.0, 54.7) | 0.788 |
AST (U/L) | 40.0 (30.0, 58.0) | 38.0 (29.0, 55.0) | 34.1 (26.0, 54.0) | <0.001 |
CR (μmol/L) | 77.0 (68.0, 88.0) | 79.0 (68.0, 89.0) | 69.0 (61.0, 78.0) | <0.001 |
BUN (mmol/L) | 4.9 (4.1, 5.9) | 5.0 (4.2, 5.9) | 5.4 (4.5, 6.4) | <0.001 |
PT (s) | 12.8 (12.1, 18.6) | 13.0 (12.2, 18.0) | 12.0 (11.5, 18.8) | <0.001 |
INR | 1.05 (0.98, 1.13) | 1.06 (1.00, 1.16) | 1.01 (0.96, 1.07) | <0.001 |
AFP ≥400 / < 400 (ng/mL) | 388 (43.1%) / 512 (56.9%) | 142 (47.3%) / 158 (52.7%) | 130 (33.6%) / 257 (66.4%) | <0.001 |
CSPH, Yes / NO | 75 (8.3) / 825 (91.7) | 31 (10.3) / 269 (89.7) | 95 (24.5) / 292 (75.5) | <0.001 |
Child-Pugh grade A / B (7 score) | 858 (95.3%) / 42 (4.7%) | 284 (94.7%) / 16 (5.3%) | 373 (96.4%) / 14 (3.6%) | 0.541 |
MELD score | 4 (2, 7) | 5 (3, 7) | 4 (2, 5) | <0.001 |
ALBI score | −2.63 ± 0.41 | −2.61 ± 0.45 | −2.76 ± 0.40 | <0.001 |
PALBI score | −2.47 (−2.67, −2.25) | −2.43 (−2.67, −2.17) | −2.64 (−2.80, − 2.41) | <0.001 |
APRI score | 0.52 (0.35, 0.84) | 0.48 (0.34, 0.85) | 0.64 (0.38, 1.19) | <0.001 |
Tumour size (cm) | 6.1 (4.0, 17.5) | 6.8 (4.0, 16.5) | 5.7 (4, 18) | 0.387 |
Tumour number, Multiple/ Single | 239 (26.6%) / 661 (73.4%) | 73 (24.3%) / 227 (75.7%) | 101 (25.9%) / 286 (74.1%) | <0.001 |
Portal invasion, Yes / No | 103 (11.4%) / 761 (84.6%) | 29 (9.7%) / 271 (90.3%) | 30 (7.7%) / 357 (92.3%) | 0.393 |
BCLC stage | 0.001 | |||
0 | 31 (3.4%) | 12 (4.0%) | 29 (7.5%) | |
A | 560 (62.2%) | 197 (65.7%) | 242 (62.5%) | |
B | 206 (22.9%) | 62 (20.6%) | 82 (21.3%) | |
C | 103 (11.5%) | 29 (9.7%) | 34 (8.7%) | |
Operation time (min) | 193 (160, 240) | 200 (165, 250) | 190 (160, 240) | 0.172 |
Blood loss, ≥400 / < 400 (mL) | 346 (38.4%) / 554 (61.6%) | 114 (38.0%) / 186 (62.0%) | 136 (35.1%) / 251 (64.9%) | <0.001 |
Blood transfusion, Yes / No | 59 (6.6%) / 841 (93.4%) | 21 (7.0%) / 279 (93.0%) | 42 (10.9%) / 345 (89.1%) | 0.026 |
eTLV (mL) | 1212.2 ± 109.6 | 1208.6 ± 107.5 | 1212.0 ± 113.0 | 0.874 |
FLR (mL) | 939.6 (791.2, 1042.5) | 919.8 (780.8, 1028.8) | 948.2 (840.6, 1045.9) | 0.053 |
sFLR (%) | 69.0 (34.0, 85.0) | 67.9 (36.0, 84.2) | 69.6 (37.0, 86.0) | 0.013 |
Hepatic vascular occlusion | 0.903 | |||
No | 243 (27.0%) | 80 (26.7%) | 111 (28.7%) | |
HVC | 283 (31.4%) | 89 (29.7%) | 114 (29.5%) | |
THVE | 374 (41.6%) | 131 (43.7%) | 162 (41.8%) | |
Cirrhosis, Yes / No | 389 (43.2%) / 511 (56.8%) | 149 (49.7%) / 151 (50.3%) | 190 (49.1%) / 197 (51.9%) | 0.052 |
PHLF | 214 (23.8%) / 686 (76.2%) | 63 (21.0%) / 237 (79.0%) | 145 (37.5) / 242 (62.5%) | <0.001 |
Grade A | 93 (10.3%) | 30 (10.0%) | 67 (17.3%) | <0.001 |
Grade B | 114 (12.7%) | 32 (10.7%) | 70 (18.1%) | |
Grade C | 7 (0.8%) | 1 (0.3%) | 8 (2.1%) | |
Grade B/C | 121 (13.5%)/779 (86.5%) | 33 (11.0%) / 267 (89.0%) | 78 (20.2%) / 309 (79.8%) | 0.001 |